Samer A Srour

Samar A Srour is an Assistant Professor at The University of Texas MD Anderson Cancer Center, specializing in hematology, oncology, and stem cell transplantation. His research focuses on optimizing allogeneic and autologous transplantation outcomes, including donor selection strategies, graft composition, and cellular therapies for solid tumors. He has led pivotal work on the BMT CTN 1702 trial, examining alternative donor transplantation, and has published on renal function impacts in AL amyloidosis and the safety of bispecific antibodies. His recent investigations into myeloablative Orca-Q therapy and donor characteristics aim to improve transplant accessibility and efficacy across diverse patient populations.